Therapeutics Company Reveals Pre-clinical Data For Integrase Technology
The MINT platform, derived from Sangamo's extensive experience in protein-DNA interactions through its zinc finger technology.
As an investor it's important to stay updated with major news. Get real-time stock market alerts, news, and research by creating an account here.